OBJECTIVE
To evaluate the influence of primary care physicians' attitudes toward and use of information provided by pharmaceutical representatives on prescribing costs in ambulatory practice.
DESIGN
A mailed questionnaire collected information about physician demographic and practice characteristics and attitudes toward and use of information provided by pharmaceutical representatives.
PARTICIPANTS
Kentucky physicians practicing primary care adult medicine (family medicine, general practice, general medicine; n = 1603).
MAIN OUTCOME MEASURE
Relative cost of prescribing, based on physician responses to treatment choices for ambulatory clinical scenarios in primary care. A multivariable regression model assessed predictive relationships between independent variables and prescription costs.
RESULTS
Four hundred forty-six returned questionnaires were suitable for analysis. No significant differences were noted in age, gender, days worked per week, or years since graduation between responders and a sample of nonresponders. A significant positive correlation was found between physician cost of prescribing and perceived credibility, availability, applicability, and use of information provided by pharmaceutical representatives (P < .01, Pearson's Product-Moment Correlation Coefficient). Physicians in academic or hospital-based practice settings had significantly lower prescribing costs than physicians in nonacademic and nonhospital practices (P = .001, analysis of variance). Frequency of use of information provided by pharmaceutical representatives (P = .01, multiple linear regression) and the group practice setting (P = .02, multiple linear regression) remained significant, independent positive predictors of cost in the multivariable regression model.
CONCLUSIONS
Frequency of use of information provided by pharmaceutical representatives and the group practice, nonacademic and nonhospital setting may be associated with increased primary care physician prescribing costs.
[1]
R Hartley,et al.
Scientific versus commercial sources of influence on the prescribing behavior of physicians.
,
1982,
The American journal of medicine.
[2]
C. W. Gowdey,et al.
A survey of physicians' reactions to drug promotion.
,
1968,
Canadian Medical Association journal.
[3]
M. Rawlins.
DOCTORS AND THE DRUG MAKERS
,
1984,
The Lancet.
[4]
E. Hemminki,et al.
Review of literature on the factors affecting drug prescribing.
,
1975,
Social science & medicine.
[5]
H. Dorkin,et al.
Undesirable marketing practices in the pharmaceutical industry.
,
1985,
The New England journal of medicine.
[6]
L. Lasagna,et al.
Correlates of physicians' prescribing behavior.
,
1972,
Inquiry : a journal of medical care organization, provision and financing.
[7]
G Eaton,et al.
Sources of drug information used by general practitioners.
,
1976,
The Journal of the Royal College of General Practitioners.
[8]
D P Connelly,et al.
Knowledge resource preferences of family physicians.
,
1990,
The Journal of family practice.
[9]
Bower Ad,et al.
Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices.
,
1987
.
[10]
G Eaton,et al.
General practitioners' views of information about drugs.
,
1976,
The Journal of the Royal College of General Practitioners.